NEO logo

NeoGenomics (NEO) Company Overview

Profile

Full Name:

NeoGenomics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

March 16, 2004

Indexes:

Not included

Description:

NeoGenomics, Inc. is one of the leading companies in cancer diagnostics and pharmaceutical services, serving oncologists, pathologists, pharmaceutical companies, academic centers, and other specialists with innovative diagnostic and prognostic tests. The company was founded in 2002, with headquarters located in Fort Myers, Florida, USA. The clinical services segment provides cancer testing services for pathologists, oncologists, dermatologists, and other clinicians representing various communities, hospitals, and centers. The company is a leading provider of molecular sequencing and next-generation testing. The pharmaceutical services segment offers comprehensive testing services to support pharmaceutical clients' oncology programs from discovery to commercialization.

Events Calendar

Earnings

Next earnings date:

Apr 30, 2025

Recent quarterly earnings:

Feb 18, 2025

Recent annual earnings:

Feb 18, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 16, 2003

Analyst ratings

Recent major analysts updates

Feb 19, 25 Needham
Buy
Feb 19, 25 B of A Securities
Neutral
Jan 28, 25 Goldman Sachs
Buy
Jan 16, 25 Benchmark
Hold
Jan 15, 25 Needham
Buy
Jan 13, 25 Benchmark
Hold
Jan 10, 25 Needham
Buy
Dec 13, 24 B of A Securities
Neutral
Dec 10, 24 Jefferies
Buy
Nov 6, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for NeoGenomics?
  • Does NeoGenomics pay dividends?
  • What sector is NeoGenomics in?
  • What industry is NeoGenomics in?
  • What country is NeoGenomics based in?
  • When did NeoGenomics go public?
  • Is NeoGenomics in the S&P 500?
  • Is NeoGenomics in the NASDAQ 100?
  • Is NeoGenomics in the Dow Jones?
  • When was NeoGenomics's last earnings report?
  • When does NeoGenomics report earnings?
  • Should I buy NeoGenomics stock now?

What is the ticker symbol for NeoGenomics?

The ticker symbol for NeoGenomics is NASDAQ:NEO

Does NeoGenomics pay dividends?

No, NeoGenomics does not pay dividends

What sector is NeoGenomics in?

NeoGenomics is in the Healthcare sector

What industry is NeoGenomics in?

NeoGenomics is in the Diagnostics & Research industry

What country is NeoGenomics based in?

NeoGenomics is headquartered in United States

When did NeoGenomics go public?

NeoGenomics's initial public offering (IPO) was on March 16, 2004

Is NeoGenomics in the S&P 500?

No, NeoGenomics is not included in the S&P 500 index

Is NeoGenomics in the NASDAQ 100?

No, NeoGenomics is not included in the NASDAQ 100 index

Is NeoGenomics in the Dow Jones?

No, NeoGenomics is not included in the Dow Jones index

When was NeoGenomics's last earnings report?

NeoGenomics's most recent earnings report was on Feb 18, 2025

When does NeoGenomics report earnings?

The next expected earnings date for NeoGenomics is Apr 30, 2025

Should I buy NeoGenomics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions